Global tissue and organ transplantation market is estimated to be valued at USD 18.75 Bn in 2025 and is expected to reach USD 35.65 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.6% from 2025 to 2032.
To learn more about this report, Request sample copy
Growing prevalence of chronic diseases such as cancer, cardiovascular diseases, kidney diseases, and liver diseases boosts demand for tissue and organ transplantation procedures. Rising aging population worldwide also boosts demand for transplantation as aging increases the risk of developing health conditions that require tissue or organ transplant. Furthermore, technological developments in transplantation procedures and increased government funding & initiatives to promote organ donation can drive the global tissue and organ transplantation market during the forecast period.
Aging Population and Growing Diseases
Due to advancement in medical field, there has been increase in average life expectancy across the world. However, increasing age leads to several chronic diseases and health conditions that may damage vital organs beyond repair over time. Growing elderly population globally can lead to increase in cases of end-stage renal disease, cardiovascular failure, cancer, and other degenerative diseases, which can be treated by transplantation only. Modern unhealthy lifestyle practices causes younger people to develop cardiovascular and liver conditions earlier in their lives. Thus, there is huge demand for lifesaving organ transplantation procedures like kidney, heart, and liver transplants. According to some estimates, over 113,000 patients worldwide are currently in need of an organ transplant but very few matching donors are available. The healthcare industry and governments across nations are focusing more on bridging this gap between demand and supply to save more lives. For instance, according to the data published on World Kidney Day in March 2020, a collaboration between the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations (IFKF), kidney disease affected approximately 850 million people worldwide. According to the Globocan 2020 report from the Global Cancer Observatory, a platform that estimates the incidence and mortality of 36 types of cancer across 185 countries, 19,292,789 new cases of cancer were diagnosed in 2020, resulting in approximately 9,958,133 deaths from cancer.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients